Global Antidiabetics Market Trends, Applications, Analysis, Growth, and Forecast to 2027

MarketResearch.biz, in its upcoming report titled, “Global Antidiabetics Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global antidiabetics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global antidiabetics market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global antidiabetics market is estimated to exhibit a X.X% CAGR in terms of value during the forecast period 2018–2027. The global market report has been segmented on the basis of product, application and region.

Request Covid - 19 Impact

Diabetes is a chronic metabolic disease wherein the body is either not able to produce insulin (type-1) or is not able to utilize the generated insulin (type-2). Diabetes is type of metabolic diseases in which the person has high blood glucose (blood sugar), due to inadequate insulin production, or body's cells not responding properly to insulin or both. Patients with elevated sugar level experience various symptoms such as increased thirst (polydipsia), weight loss, increased appetite (polyphagia) and frequent and sweet-smelling urination (polyuria). If untreated, diabetes causes various acute and chronic life-threatening complications.

Diabetes may occur in any individual regardless of their age or gender. Overweight and obese people, and people with unhealthy diets and less physical activity are more prone to diabetes. Diabetes may lead to many major consequences such as blindness, amputations, kidney failure, and higher risk of death.

Increasing geriatric population, rising prevalence of obesity among population due to various reasons such as unhealthy lifestyles, and stressful and round-the-clock working conditions are key factors driving the global antidiabetics market. In addition, governments initiatives to educate and spread awareness, improvement in diabetes treatment and products innovations are also fueling the market growth.

Drug patent expiry, high-cost associated with diagnosis and treatments, poor reimbursement policies may hamper growth of the global antidiabetics market. However, generic drugs manufacturers have opportunities to expand their customer base and generate revenues from biosimilar products. Biosimilars are required due to patent expiration of major popular products. Moreover, emerging countries offer a strong platform with unmet medical needs.

North America market is estimated to account for comparatively higher share owing to better healthcare infrastructure, high expenditure on healthcare, favorable reimbursement policies, and penetration of long acting and rapid acting insulin analogs in countries of this region. Asia pacific is expected to witness highest growth during the forecast period owing to government initiatives to improve healthcare facilities and spread awareness, high disposable incomes, prevalence of type I and type II diabetes due to unhealthy lifestyles, and increasing geriatric and obese population.

Global Antidiabetics Market Segmentation:

Global Antidiabetics Market Segmentation by Product

• Insulin
• Rapid Acting
• Long Acting
• Premixed
• Short Acting
• Intermediate Acting
• Other Antidiabetics
• Alpha-Glucosidase Inhibitors
• Biguanides
• Sulphonylureas
• GLP-1 Agonist
• Meglitinides
• DPP-4 Inhibitors
• SGLT-2
• Thiazolodinediones

Global Antidiabetics Market Segmentation by application

• Type I
• Type II and Other Diabetes

Global Antidiabetics Market Segmentation by region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa